CME Peer-to-Peer Podcast
The HCVcme.org™ Podcast series features insightful, in-depth audio commentary from a prestigious group of HCV experts. Listen in for the state-of-the-art information as they address timely, clinically relevant topics on the management and treatment of HCV among special patient populations.
Earn AMA PRA Category 1 Credits™!
This section offers downloads of audio files. If you do not have a Media Player, you can acquire one by clicking one of the following:
| Download Windows Media Player® | Download iTunes® | Subscribe to Podcast | RSS Feed |
Topic: Focus on Triple Therapy in Patient Populations at High Risk for HCV in the
Community Health Setting
Listen to HCV experts, Doctors Gardenier, Jeffers, and Pearlman, as they address timely, clinically relevant topics on the management and treatment of HCV for patient populations at high risk in the urban setting, the homeless, those with injection drug use, those formerly incarcerated, minorities, and the impoverished and underserved.
Donald Gardenier, DNP, FNP-BC
Mount Sinai School of Medicine
Lennox J. Jeffers, MD
University of Miami School of Medicine
Brian L. Pearlman, MD
Atlanta Medical Center
![]() |
Part 1 Focusing on Patient Populations at High Risk for HCV in the Community Health Setting |
|
![]() |
Part 2 New Treatment Paradigms for HCV |
|
![]() |
Part 3 Integrated Models of Care for Patients with HCV |
|
Topic: Focus on Triple Therapy in Patients with Comorbidities
Listen to HCV experts, Doctors Ho, Morgan, and Sjogren, as they address timely, clinically relevant topics on the management and treatment of HCV for patients with comorbidities such as drug abuse, alcoholism, and psychological issues.
Samuel B. Ho, MD
University of California, San Diego
Timothy R. Morgan, MD
University of California, Irvine
Maria H. Sjogren, MD, MPH, FACP, FACG
Walter Reed Army Medical Center
![]() |
Part 1 Focusing on Patient Populations with Comorbidities |
|
![]() |
Part 2 New Treatment Paradigms for HCV |
|
![]() |
Part 3 Integrated Models of Care for Patients with HCV |
|













